Navigation Links
Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference

SUNNYVALE, Calif., June 4 /PRNewswire-FirstCall/ --- Cepheid (Nasdaq: CPHD) today announced speaker and program highlights for its symposium, "On-Demand HAI Testing: Good Medicine and Good Business," which the company will host at the 2009 Association for Professionals in Infection Control (APIC) annual conference, taking place in Fort Lauderdale, Florida, June 7th - 10th. Cepheid's GeneXpert(R) Systems and menu of molecular diagnostic tests will be on display in booth #906 on the exhibition floor.

"Management and prevention of Healthcare Associated Infections (HAIs) is a shared responsibility that includes the entire healthcare industry," said Sandra Finley, Cepheid's Vice President of Marketing. "We are pleased to present industry experts who will discuss the importance of reducing and eliminating HAI infections and the operational benefits that these investments bring in quality improvements, patient outcomes, and hospital throughput efficiencies."

The symposium, "On-Demand HAI Testing: Good Medicine and Good Business," is scheduled for Wednesday, June 10, 2009 from 11:30 a.m. to 1:30 p.m. EST. Interested parties, unable to attend the APIC conference, are invited to listen to the event live via webcast. To access the live webcast, please register through Cepheid's website at at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. APIC attendees can register to attend this exhibitor-sponsored symposium while at the conference.

The scheduled presenters are:

    Jorge P. Parada, MD, MPH
    Associate Professor
    Medical Director Infection Control Program
    Researcher Associate, Infectious Diseases and Immunology Institute (inDII)
    Stritch School of Medicine Loyola University Chicago

    William J. Ward, Jr., MBA
    Associate Professor
    Director, MHS Degree in Health Finance and Management
    Sommer Scholars Program Faculty Director
    Johns Hopkins Bloomberg School of Public Health

    Fred C. Tenover, Ph.D., D (ABMM)
    Senior Director, Scientific Affairs, Cepheid
    Adjunct Professor of Epidemiology, Rollins School
    of Public Health, Emory University, Atlanta, GA

Healthcare-associated infections exact a significant toll on human life, and are among the top ten leading causes of death in the United States. Recent reports estimate hospital stays for Methicillin-resistant Staphylococcus aureus (MRSA) infection have more than tripled since 2000 and represent $20 billion in excess healthcare costs each year. Similarly, Clostridium difficile infections have been increasing in incidence and severity, and have become a substantive and growing burden in hospitalized patients, prompting the need for earlier and accurate detection.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See for more information.

    For Media Inquiries:                   For Cepheid Investor Inquiries:
    --------------------                   -------------------------------
    Jared Tipton                           Jacquie Ross
    Cepheid Corporate Communications       Cepheid Investor Relations
    408-400-8377                           408-400-8329     

SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference
2. Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
3. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
4. Cepheid to Present at the Needham Tenth Annual Growth Stock Conference
5. Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
6. Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing
7. Cepheid Reports Record Revenue of $44.8 Million
8. Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations
9. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
10. Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
11. Cepheid Reports Fourth Quarter and Full Year 2008 Results
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... ... 27, 2016 , ... A revolution is underway. Brooklyn-based ... experience for the millions of people who require these medical transport services annually. ... through the use of technology. Now, SmartEMS has put forth an industry-changing app ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer ... through a fitness app. The fitness app plans to fix the two major problems leading ... a one size fits all type program , They don’t eliminate all the ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: